Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Polycystic Ovary Syndrome 1Motor Activity 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 637Bevacizumab 552Paclitaxel 533Carboplatin 531Cisplatin 478pembrolizumab 452Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 371Dexamethasone 349Doxorubicin 325Nivolumab 307Fluorouracil 286Capecitabine 260Prednisone 243Oxaliplatin 242Erlotinib Hydrochloride 242Etoposide 239Lenalidomide 231Cytarabine 230Trastuzumab 227Pemetrexed 219fludarabine phosphate 207Vincristine 207Leucovorin 207Cetuximab 207Filgrastim 204Bortezomib 191Methotrexate 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × High-Intensity Interval Training × Clear all
NCT03823651 2024-09-27

A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)

Duke University

Phase NA Completed
29 enrolled 14 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT04942366 2024-02-02

High-Intensity Interval Training On Women With Polycystic Ovary Syndrome.

Ziauddin University

Phase NA Completed
50 enrolled 7 charts

Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡